GlaxoSmithKline
China launches probe on GSK over price fixing
05 Jul 2013
GSK accused of paying off rivals to delay entry of generic drugs
19 Apr 2013
The UK regulator today said that GSK has made substantial payments to three smaller rivals to stop them from releasing generic versions of its paroxetine anti-depressant drug Seroxat